These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1684486)

  • 1. Effects of beta-adrenergic blocking agents on specific binding of [3H]D-Ala2-Met5-enkephalinamide and [3H]naloxone.
    Takayama H; Ogawa N; Asanuma M; Hirata H; Ogura T; Ota Z
    Acta Med Okayama; 1991 Oct; 45(5):295-9. PubMed ID: 1684486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of catecholamine-derived alkaloids and beta-adrenergic blocking agents on stereospecific binding of 3H-naloxone.
    Tampier L; Alpers HS; Davis VE
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):731-4. PubMed ID: 19827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different changes by acute electric footshock of opioid agonist and antagonist receptors in rat brain.
    Kameyama T; Nabeshima T; Matsuno K; Suzuki M
    Neurosci Lett; 1984 Aug; 49(3):307-12. PubMed ID: 6093006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat.
    Nabeshima T; Matsuno K; Kameyama T
    Eur J Pharmacol; 1985 Aug; 114(2):197-207. PubMed ID: 2995079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electric footshock-induced changes in behavior and opioid receptor function.
    Nabeshima T; Matsuno K; Kamei H; Noda Y; Kameyama T
    Pharmacol Biochem Behav; 1985 Nov; 23(5):769-75. PubMed ID: 3001781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mu-selective Met-enkephalinamide analogs with antagonist activity. Synthesis, receptor binding, analgesic properties and conformational studies.
    Judd AK; Lawson JA; Olsen CM; Toll LR; Polgar WE; Uyeno ET; Keys CJ; Loew GH
    Int J Pept Protein Res; 1987 Sep; 30(3):299-317. PubMed ID: 2826356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenesis of opiate receptors in regions of the ovine brain.
    Villiger JW; Taylor KM; Gluckman PD
    Pediatr Pharmacol (New York); 1982; 2(4):349-56. PubMed ID: 6099887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration, characterization and localization of opioid binding sites in the midgut of the insect Leucophaea maderae (Blattaria).
    Stefano GB; Scharrer B; Assanah P
    Brain Res; 1982 Dec; 253(1-2):205-12. PubMed ID: 6295551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
    Schoffelmeer AN; Warden G; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1991 Jul; 258(1):237-42. PubMed ID: 1677039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentazocine and concomitant clonidine on opioid receptors in the rat brain.
    Ogawa N; Hirose Y; Kuroda H; Takayama H
    Acta Med Okayama; 1985 Jun; 39(3):217-20. PubMed ID: 2992233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
    Wong TM; Chan SH; Tse SY
    Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
    Kapusta DR; Jones SY; Kopp UC; Dibona GF
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1039-47. PubMed ID: 2703962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin, substance P and [Lys]-vasopressin interfere with the binding of [3H][D-Ala2, Met5]enkephalinamide to rat brain membranes.
    Maruyama M
    Jpn J Pharmacol; 1985 Aug; 38(4):445-7. PubMed ID: 2415736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy.
    Jefferys D; Copolov D; Funder JW
    Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.